Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon - A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.

A.E. Gliddon, C.J. Dore, C.M. Black, N. McHugh, R. Moots, C.P. Denton, A. Herrick, T. Barnes, J. Camilleri, K. Chakravarty, P. Emery, B. Griffiths, N.D. Hopkinson, P. Hickling, P. Lanyon, C. Laversuch, T. Lawson, R. Mallya, M. Nisar, C. Rhys-DillonT. Sheeran, P.J. Maddison

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)3837-3846
    JournalArthritis and Rheumatism
    Volume56
    Issue number11
    DOIs
    Publication statusPublished - 1 Nov 2007

    Keywords

    • RHEUMATOLOGY

    Cite this